Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Martin Maron MD

Martin S. Maron MD

Director, Hypertrophic Cardiomyopathy Center, Lahey Hospital, Burlington, Massachusetts

Dr. Martin Maron is the Director of the Hypertrophic Cardiomyopathy Center at Lahey Hospital in Burlington, Massachusetts, Previous, Dr. Maron was an Assistant Professor of Medicine and Director of the Hypertrophic Cardiomyopathy Center and Co-Director of Advanced Cardiac Imaging at Tufts Medical Center. His research interests involve the role of cardiovascular magnetic resonance (CMR) in the evaluation and management of patients with HCM as well as investigating novel drug therapy to modify the HCM phenotype. Over the last 6 years, Dr. Maron has co-authored over 50 original publications in HCM including first author publications in New England Journal of Medicine, Circulation and Journal of the American College of Cardiology. 

Recent Contributions to PracticeUpdate:

  1. Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy
  2. Transcatheter Myotomy to Reduce LVOT Obstruction
  3. Radiomics of LGE Reveals Prognostic Value of Myocardial Scar Heterogeneity in Hypertrophic Cardiomyopathy
  4. Assessment of LGE in Patients With HCM Improves Risk Stratification Based on Current Guidelines
  5. Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy
  6. Exercise Test Abnormalities as a Predictor of Sudden Cardiac Death and Transplant-Free Survival in Childhood HCM
  7. Survival Following Alcohol Septal Ablation or Septal Myectomy in Patients With Obstructive Hypertrophic Cardiomyopathy
  8. Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive Cardiomyopathy
  9. Epidemiology of Cardiomyopathies and Incident Heart Failure
  10. Maximal Wall Thickness Measurement in Hypertrophic Cardiomyopathy

Most Read This Week

Recently Updated